Elsevier Announces Publishing of The American Journal of Pathology (AJP) on Behalf of the American Society for Investigative Pathology (ASIP)

By Elsevier, PRNE
Monday, October 11, 2010

PHILADELPHIA, October 12, 2010 - Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, is pleased to announce that as of January
2011
Elsevier will publish The American Journal of Pathology (AJP) in
partnership with the American Society for Investigative Pathology (ASIP).

The American Journal of Pathology is the official publication of the
American Society for Investigative Pathology. Under the guidance of
Editor-in-Chief Michael P. Lisanti, MD, PhD, Thomas Jefferson University,
Philadelphia, PA, AJP is a monthly, peer-reviewed, scholarly publication that
reports cutting-edge science which advances basic and translational knowledge
of disease pathogenesis, classification, and diagnosis, as well as basic
biological mechanisms relating to disease. It is the leading global forum for
reporting quality original research on cellular and molecular mechanisms of
disease. Articles include studies on human disease and relevant experimental
models using cellular, molecular, animal, biological, chemical, and
immunological approaches in conjunction with morphology.

"Elsevier is truly honored to partner with the American Society for
Investigative Pathology to publish The American Journal of Pathology. This
premier journal represents the highest-quality research, covering a broad
range of topics and specialties. As such, the fit with our current publishing
program is excellent," states Andrew Berin, Publishing Director, Elsevier.

Dr. Mark E. Sobel, ASIP's Executive Officer, states, "ASIP looks forward
to its partnership with Elsevier, which will serve to further the Society's
mission of disseminating high-quality research and information about the
cellular and molecular mechanisms of disease. We are confident that
Elsevier's expertise, innovative technology, and global presence will serve
to expand the reach and impact of our flagship journal, The American Journal
of Pathology."

About The American Society for Investigative Pathology (ASIP)

The American Society for Investigative Pathology is an educational
professional not-for-profit society dedicated to the discovery, advancement,
and dissemination of basic and translational knowledge in experimental
pathology and related disciplines. This is achieved by fostering
investigation into the pathogenesis, classification, diagnosis, and
manifestations of disease through meetings, publications, and educational
activities. Investigative pathology is an integrative discipline that links
the presentation of disease in the whole organism to its fundamental cellular
and molecular mechanisms, using a variety of structural, functional, and
genetic techniques and ultimately applies research findings to the diagnosis
and treatment of diseases. ASIP advocates for the practice of investigative
pathology and fosters the professional career development and education of
its members. For more information, please visit: www.asip.org

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com/) and Cell
9www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/home.url), Reaxys (
notice.reaxys.com/maintenance.html), MD Consult (
www.mdconsult.com/php/222075573-2/homepage) and Nursing Consult
(www.nursingconsult.com/php/222075595-2/home.html), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com/) and MEDai's Pinpoint Review (www.medai.com/),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC (
www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and
information provider, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Andrew Berin
    Publishing Director, Elsevier
    +1-212-633-3887
    a.berin@elsevier.com

    ajp.amjpathol.org/
    jmd.amjpathol.org/

Media Contact: Andrew Berin, Publishing Director, Elsevier, +1-212-633-3887, a.berin at elsevier.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :